ArticleCancer research communications2024

ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Nab-Paclitaxel in Patients with Advanced Solid Tumors.

Christopher T Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.